These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20070543)

  • 21. A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging.
    Yu CM; Zhang Q; Fung JW; Chan HC; Chan YS; Yip GW; Kong SL; Lin H; Zhang Y; Sanderson JE
    J Am Coll Cardiol; 2005 Mar; 45(5):677-84. PubMed ID: 15734610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure.
    St John Sutton MG; Plappert T; Abraham WT; Smith AL; DeLurgio DB; Leon AR; Loh E; Kocovic DZ; Fisher WG; Ellestad M; Messenger J; Kruger K; Hilpisch KE; Hill MR;
    Circulation; 2003 Apr; 107(15):1985-90. PubMed ID: 12668512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
    Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
    JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of interlead distance on immediate and mid-term response to cardiac resynchronization therapy.
    Wang J; Su Y; Cui J; Chen H; Qin S; Ge J
    Scand Cardiovasc J; 2013 Oct; 47(5):263-70. PubMed ID: 23941703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.
    Bax JJ; Bleeker GB; Marwick TH; Molhoek SG; Boersma E; Steendijk P; van der Wall EE; Schalij MJ
    J Am Coll Cardiol; 2004 Nov; 44(9):1834-40. PubMed ID: 15519016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Right ventricular lead adjustment in cardiac resynchronization therapy and acute hemodynamic response: a pilot study.
    Kumar P; Upadhyay GA; Cavaliere-Ogus C; Heist EK; Altman RK; Chatterjee NA; Parks KA; Singh JP
    J Interv Card Electrophysiol; 2013 Apr; 36(3):223-31. PubMed ID: 23263893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of resynchronization therapy on cardiac function in pacemaker patients "upgraded" to biventricular devices.
    Horwich T; Foster E; De Marco T; Tseng Z; Saxon L
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1284-9. PubMed ID: 15574179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of left ventricular systolic dyssynchrony by real-time three-dimensional echocardiography to predict long-term response to cardiac resynchronization therapy.
    Soliman OI; Geleijnse ML; Theuns DA; van Dalen BM; Vletter WB; Jordaens LJ; Metawei AK; Al-Amin AM; ten Cate FJ
    Am J Cardiol; 2009 Jun; 103(11):1586-91. PubMed ID: 19463520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of baseline left lateral wall postsystolic displacement assessed by M-mode to predict reverse remodeling by cardiac resynchronization therapy.
    Sassone B; Capecchi A; Boggian G; Gabrieli L; Saccà S; Vandelli R; Petracci E; Mele D
    Am J Cardiol; 2007 Aug; 100(3):470-5. PubMed ID: 17659931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relation of response to cardiac resynchronization therapy to left ventricular reverse remodeling.
    Vidal B; Sitges M; Marigliano A; Díaz-Infante E; Azqueta M; Tamborero D; Macías A; Roig E; Brugada J; Paré C; Mont L
    Am J Cardiol; 2006 Mar; 97(6):876-81. PubMed ID: 16516593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure.
    St John Sutton M; Ghio S; Plappert T; Tavazzi L; Scelsi L; Daubert C; Abraham WT; Gold MR; Hassager C; Herre JM; Linde C;
    Circulation; 2009 Nov; 120(19):1858-65. PubMed ID: 19858419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure.
    Porciani MC; Macioce R; Demarchi G; Chiostri M; Musilli N; Cappelli F; Lilli A; Ricciardi G; Padeletti L
    Eur J Echocardiogr; 2006 Jan; 7(1):31-9. PubMed ID: 16378918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
    Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
    Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of atrial function and atrial reverse remodeling after cardiac resynchronization therapy for heart failure.
    Yu CM; Fang F; Zhang Q; Yip GW; Li CM; Chan JY; Wu L; Fung JW
    J Am Coll Cardiol; 2007 Aug; 50(8):778-85. PubMed ID: 17707183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durations.
    Zhang Q; Chan YS; Liang YJ; Fang F; Lam YY; Chan CP; Lee AP; Chan KC; Wu EB; Yu CM
    Int J Cardiol; 2013 Aug; 167(3):889-93. PubMed ID: 22330007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment.
    Inage T; Yoshida T; Hiraki T; Ohe M; Takeuchi T; Nagamoto Y; Fukuda Y; Gondo T; Imaizumi T
    Europace; 2008 Mar; 10(3):379-83. PubMed ID: 18227354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left Ventricular Reverse Remodeling With Biventricular Versus Right Ventricular Pacing in Patients With Atrioventricular Block and Heart Failure in the BLOCK HF Trial.
    St John Sutton M; Plappert T; Adamson PB; Li P; Christman SA; Chung ES; Curtis AB
    Circ Heart Fail; 2015 May; 8(3):510-8. PubMed ID: 25697851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.